Nippon India Pharma Fund
The fund maintains a concentrated bet on large-cap pharma majors, with Sun Pharma, Lupin, and Dr. Reddy's anchoring nearly 29% of assets, while healthcare services add defensive diversification through Apollo and diagnostic plays. The exit of JB Chemicals and increased conviction in Dr. Reddy's signal confidence in established, cash-generative players over mid-cap names, positioning the portfolio for sustained dividend yields rather than growth. At 98.7% equity with minimal cash, the manager shows commitment to sector exposure despite volatile macro conditions.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| Regular Growth | ₹531.8502 | +7.05% | — | — | — | — | — |
| Regular Growth | ₹531.8502 | +7.05% | +5.84% | +2.44% | +7.72% | +23.21% | +13.19% |
Portfolio Metrics(latest month)
What Changed2026-03-31 → 2026-04-30
| Stock | Weight | |
|---|---|---|
| No new entries this month | ||
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited INE044A01036 | 13.85% |
| 2 | Lupin Limited INE326A01037 | 7.95% |
| 3 | Dr. Reddy's Laboratories Limited INE089A01031 | 7.04% |
| 4 | Divi's Laboratories Limited INE361B01024 | 6.61% |
| 5 | Cipla Limited INE059A01026 | 5.47% |
| 6 | Apollo Hospitals Enterprise Limited INE437A01024 | 5.01% |
| 7 | MedPlus Health Services Limited INE804L01022 | 3.78% |
| 8 | Vijaya Diagnostic Centre Limited INE043W01024 | 3.36% |
| 9 | Sai Life Sciences Limited INE570L01029 | 3.27% |
| 10 | Ajanta Pharma Limited INE031B01049 | 3.19% |
| 11 | Max Healthcare Institute Limited INE027H01010 | 3.16% |
| 12 | Mankind Pharma Limited INE634S01028 | 3.04% |
| 13 | Aurobindo Pharma Limited INE406A01037 | 2.83% |
| 14 | GlaxoSmithKline Pharmaceuticals Limited INE159A01016 | 2.55% |
| 15 | IPCA Laboratories Limited INE571A01038 | 2.50% |
| 16 | Abbott India Limited INE358A01014 | 2.26% |
| 17 | Thyrocare Technologies Limited INE594H01019 | 2.11% |
| 18 | Alkem Laboratories Limited INE540L01014 | 2.09% |
| 19 | Dr. Lal Path Labs Limited INE600L01024 | 1.99% |
| 20 | Pfizer Limited INE182A01018 | 1.79% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.